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N proteinMeasles virus (MV) belongs to the genusMorbillivirus of the family Paramyxoviridae. A number of paramyxovi-
ruses inhibit host interferon (IFN) signaling pathways in host immune systems by various mechanisms.
Inhibition mechanisms have been described for many paramyxoviruses. Although there are inconsistencies
among previous reports concerning MV, it appears that P/V/C proteins interfere with the pathways. In this
study, we conﬁrmed the effects of MV P gene products of a wild MV strain on IFN pathways and examined
that of other viral proteins on it. Interestingly, we found that N protein acts as an IFN-α/β and γ-antagonist as
strong as P gene products. We further investigated the mechanisms of MV-N inhibition, and revealed that
MV-N blocks the nuclear import of activated STAT without preventing STAT and Jak activation or STAT degrada-
tion, and that the nuclear translocation of MV-N is important for the inhibition. The inhibitory effect of the N
protein was observed as a common feature of other morbilliviruses. The results presented in this report suggest
that N protein of MV as well as P/V/C proteins is involved in the inhibition of host IFN signaling pathways.
© 2011 Elsevier Inc. All rights reserved.Introduction
Measles virus (MV) is a leading cause of death among young
children despite the availability of a safe and effective vaccine for the
past 40 years (Moss and Grifﬁn, 2006). Vaccination has greatly limited
the spread of measles virus, and yet sufﬁcient vaccine coverage has
been difﬁcult to achieve in developing countries. Factors such as immi-
gration and public distrust of vaccine safety have contributed to local
measles outbreaks even in developed countries that include the United
States (Centers, 2008a,b; Mulholland, 2006) and Japan (Nagai et al.,
2009). A greater understanding of the molecular mechanisms underly-
ing host evasion by this pathogen would facilitate the design of new
therapeutic strategies by identifying targets for pharmacological inhibi-
tion that could augment or replace vaccinations in some situations.
MV belongs to the genusMorbillivirus of the family Paramyxoviridae.
Canine distemper virus (CDV), which has re-emerged in wild animals,
and rinderpest virus (RPV), which most closely resembles MV, also
belong to the genus Morbillivirus. Morbilliviruses are single-strand,
negative-sense RNA viruses and consist of six tandemly linked genes
that encode, from the 3′ to the 5′ end, the nucleocapsid (N), phospho
(P), matrix (M), fusion (F), hemagglutinin (H) and large (L) proteins
(Grifﬁn, 2001). In addition to coding for the P protein, the P gene of
morbillivirus encodes accessory proteins, C and V. The V protein is
translated from the same start codon as the P protein; however, an
additional nucleotide at the RNA editing site causes a frame siftrights reserved.(Cattaneo et al., 1989). Hence, V protein has a unique carboxy-
terminal domain. In contrast, the open reading frame (ORF) of C protein
begins downstream of the P protein start codon and is embedded in the
ﬁrst half of the P gene (Bellini et al., 1985).
A number of paramyxoviruses inhibit host interferon (IFN) signaling
pathways by various mechanisms involving one or more of their acces-
sory proteins. IFN-α/β (type I IFN) signals induce the phosphorylation
and activation of signal transducer and activator of transcription 1
(STAT1) and STAT2 via Janus kinase 1 (Jak1) and Tyrosine kinase 2
(Tyk2). Upon phosphorylation, STAT1 and STAT2 form heterodimers
which translocate to the nucleus, where they form IFN-stimulated
gene factor 3 (ISGF3). ISGF3 binds IFN-stimulated response elements
(ISREs) to drive the expression of IFN-α/β regulated genes. Similarly,
IFN-γ signals induce the phosphorylation and activation of STAT1 but
not STAT2 via Jak1 and Jak2. STAT1 forms homodimers and they lend
structure to the active transcription complex γ-activated factor (GAF),
which binds to γ-activated sequence (GAS) elements in regulatory
regions of IFN-γ-inducible genes (Stark et al., 1998). STAT3 is activated
bymany cytokine systems, including interleukin 6 (IL-6). In these signal
transduction pathways, the V protein of the Rubulavirus encodes STAT-
speciﬁc E3 ubiquitin ligase activities that function in combination with
cellular proteins to target STAT1 and STAT2 (and STAT3 in mumps
virus) for proteasomal degradation (Didcock et al., 1999; Parisien
et al., 2001, 2002; Ulane and Horvath, 2002; Ulane et al., 2003). The
P/V/W proteins of nipah virus (NiV), a member of the genus Henipa-
virus, block STAT1 phosphorylation (Park et al., 2003; Rodriguez et al.,
2002; Shaw et al., 2004). The C protein of Sendai virus (SeV), a member
of the genus Respirovirus, blocks IFN-γ signaling after the STAT1 nuclear
translocation event (Gotoh et al., 2004).
46 I. Takayama et al. / Virology 424 (2012) 45–55Although P/V/C proteins contribute to viral evasion of the host IFN
response in MV, various molecular mechanisms of inhibition have
been reported. V and P proteins were both found to inhibit IFN-α/β
signaling (Ohno et al., 2004), and it has been suggested that V protein
blocks the transport of IFN-α/β and IFN-γ-activated STAT molecules
to the nucleus without interfering with tyrosine phosphorylation
(Palosaari et al., 2003). Other studies found that V protein blocked
only IFN-α/β-stimulated STAT1 and STAT2 phosphorylation, without
an effect on IFN-γ action (Takeuchi et al., 2003). This ﬁnding isFig. 1. MV-N as well as MV-P/V/C is involved in the inhibition of host IFN signaling path-
ways. (A) HEK-293T cells were transfected with pISRE-Luc, phRL-TK(Int−), and either
empty vector (pCAG) or an appropriate protein (MV-N, P, V, C andM) expression plasmid.
Cells were treated with 1000 U/ml IFN-α for 24 h prior to lysis and luciferase assays.
(B) The same experiment was conducted using pGAS-Luc with 1000 U/ml IFN-γ. The
results are expressed as induction (n-fold) relative to the value obtained from experi-
mentswithout treatment. The data representmeans±SD for triplicate samples. Statistical
analysis was performed using the Student's t-test; **Pb0.01, ***Pb0.001 compared to
pCAG. (C) Western blotting for MV proteins using A lysates is shown.supported by the observation that V and C proteins both suppress
Jak1 phosphorylation by association with the IFN-α receptor complex
(Yokota et al., 2003). Shaffer et al. demonstrated the inhibition of an
IFN-α/β and IFN-γ-responsive reporter gene by C protein (Shaffer
et al., 2003). Additionally, another study also reported weak inhibition
by C protein (Fontana et al., 2008). The reasons for these discrepancies
remain unclear, although they might be due to differences in the virus
strains and cell types. To date, no studies on the effects of other viral
protein(s) on the IFN signaling pathway have been reported.
InMV and RPV infected cells, STAT1 is known to colocalize with N, P
and L proteins in cytoplasm, a pattern that has been observed for
paramyxoviruses (Nanda and Baron, 2006; Palosaari et al., 2003;
Sweetman et al., 2001). Since P protein forms a ribonucleoprotein
(RNP) complexwith N and L proteins in the infected cells, and C protein
colocalizes with them (Nakatsu et al., 2008), implication of other viral
proteins on the inhibition of IFN signaling has not been studied.
Previous studies indicated that wild-type and attenuated strains of
MV cannot be distinguished based on their sensitivity to IFN treatment
(Fontana et al., 2008). In this study, we used the HL strain, which is a
wild-type strain that was isolated from a patient and found to induce
typical symptoms of measles, including rashes and Koplik's spots, in
cynomolgus and squirrel monkeys (Kobune et al., 1996). Moreover,
the HL strain also induces inhibition of host protein synthesis (shut-off)
(Inoue et al., 2009), unlike that of the attenuated Edmonston strain
(Graves, 1981; Wechsler and Fields, 1978). Thus, it appears that the
HL strain maintains MV pathogenicity.Fig. 2. MV-N inhibits IFN-α/β and γ signaling. (A) HEK-293T cells were transfected with
pISRE-Luc, phRL-TK(Int−), and either empty vector (pCAG) or pCAG-MV-N (0.3, 0.6 and
1.2 μg/well transfected). Cells were treated with 1000 U/ml IFN-α for 24 h prior to lysis
and luciferase assays. (B) The same experiment was conducted using pGAS-Luc with
1000 U/ml IFN-γ. The results are expressed as induction (n-fold) relative to the value
obtained from experiments without treatment. The data represent means±SD for
triplicate samples.
47I. Takayama et al. / Virology 424 (2012) 45–55In the present study,we conﬁrmed the effects of the P gene products
of MV-HL strain on host IFN signaling pathways and examined that of
other viral proteins on these pathways. We found that the N protein
of MV has an inhibitory function both on IFN-α/β and IFN-γ transcrip-
tional responses for the ﬁrst time; therefore, we investigated the
molecular mechanisms of these inhibitory pathways.Fig. 3. Effect on IFN-induced phosphorylation of STATs and Jaks by MV-N. (A) HEK-293T
cellsweremock transfected or transfectedwith pCAG-MV-N expressionplasmidor empty
vector. The cells were treated 24 h later with 1000 U/ml of IFN-α at 37 °C for 10, 20 or
30 min prior to lysis. (B) HEK-293 cells were mock transfected or transfected with
pCAG-MV-N expression plasmid or empty vector. The cells were treated 24 h later with
1000 U/ml of IFN-γ at 37 °C for 10, 20, or 30 min prior to lysis. (C) To show that STAT
phosphorylation is blocked as positive control of this experiment, cells transfected with
pCAG-NiV-P were used. For STAT1, 25 μg/lane lysates were applied to SDS-PAGE on a 7%
polyacrylamide gel. For STAT2, 25 μg/lane lysates were applied to SDS-PAGE on a 5%
polyacrylamide gel. For Jak1 and Jak2, 30 μg/lane lysates were applied to SDS-PAGE on a
5% polyacrylamide gel. For GAPDH, MV-N and NiV-P, 25 μg/lane lysates were separated
by SDS-PAGE on a 10% polyacrylamide gel, and then analyzed byWestern blotting.Results
MV-N inhibits IFN-α/β and IFN-γ transcriptional responses
To conﬁrm the effect of MV P gene products on the IFN signaling
pathway in theHL strain,we investigated that of the P gene products to-
gether with other viral proteins of the MV-HL strain. We performed
luciferase reporter gene assays to detect signal transduction in response
to IFN-α/β and IFN-γ. ISRE was used as a promoter element of the
ﬁreﬂy luciferase gene to examine the response to IFN-α/β. HEK-293T
cells were transfected with the plasmid (pISRE-Luc) along with an
expression plasmid encoding various viral proteins or with empty
vector, and phRL-TK(Int−) to normalize transfection efﬁciency. At
24 h after transfection, IFN-αwas added to the cells and luciferase activ-
ity was measured 24 h later. We checked the expression levels of each
MV protein byWestern blot. The result showed that all cell lysates con-
tain enough viral protein (Fig. 1C). Expression of MV V and P proteins
almost completely blocked the induction of luciferase activity in
response to IFN-α as previously reported (Fig. 1A). In the C protein of
the HL strain, the IFN-α/β reporter gene expression level was inhibited
(36%), comparedwith transfection with the empty vector. Surprisingly,
we found that MV-N similarly interfered with IFN-α/β signaling (40%).
On the other hand, MV-M, which does not colocalize with STAT1 or
form RNP, has minor effect on this signaling pathway.
Similarly, the response to IFN-γ was tested using a GAS-luciferase
reporter gene (pGAS-Luc). MV V and P proteins induced signiﬁcant in-
hibition of the transcriptional response to IFN-γ (about 30%) in the HL
strain (Fig. 1B). MV-N also blocked the induction of luciferase activity
in response to IFN-γ (60% inhibition) more than that of MV-C. MV-MFig. 4.MV-N has no effect on the pSTAT dimer formation. (A) HEK-293T cells were trans-
fected with an empty vector (pCAG), or with MV-N expression plasmid, and then treated
with 1000 U/ml IFN-α for 6 h prior to lysis. (B) HEK-293 cells were transfected with an
empty vector, or with MV-N expression plasmid and then treated with 1000 U/ml IFN-γ
for 6 h prior to lysis. Equal amounts of lysates were subjected to native PAGE on an 8%
polyacrylamide gel. They were analyzed by Western blotting with anti-STAT1 or
anti-pSTAT1 antibody.
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MV-N, we performed luciferase reporter gene assay in cells expressing
variable concentrations of MV-N. Both IFN-α and γ signaling were
inhibited in a dose-dependent manner in cells expressing MV-N
(Figs. 2A and B). These results show that MV-N is an effective inhibitor
of IFN-α/β and IFN-γ signaling.
MV-N has no effect on STAT and Jak phosphorylation and does not induce
STAT degradation
To clarify the mechanism by which MV-N suppresses IFN signal-
ing, we ﬁrst investigated the early events of the IFN-α/β and IFN-γ
signaling pathways. First, we examined whether MV-N can preventFig. 5.MV-N prevents IFN-induced STAT nuclear accumulation. (A) COS-7 cells were transfe
at 2000 U/ml for 30 min, or not. (B) COS-7 cells were transfected with pCAG-MV-N expressio
They were ﬁxed, permeabilized, and stained with monoclonal antibody against MV-N, and p
(red) and STAT using Alexa Fluor 488 (green) secondary antibodies. For clarity, arrowheads
ber of cells displaying mainly nuclear or homogenous (nuclear+cytosolic) protein distributhe phosphorylation of STATs and Jaks. Control cells transfected with
empty vector or cells expressing MV-N were left unstimulated or
treated with IFN-α for 10 to 30 min prior to lysate preparation. We
detected the phosphorylation levels of STAT1, STAT2 and Jak1 in the
cells, with or without MV-N, by Western blot. Fig. 3A shows that the
expression of MV-N did not detectably reduce IFN-α-induced
phosphorylation of STAT1, STAT2 and Jak1. Furthermore, wemonitored
the phosphorylation of STAT1, Jak1 and Jak2 in cells with or without
MV-N treated with IFN-γ. The results showed that MV-N also did not
affect the IFN-γ-induced phosphorylation of STAT1, Jak1 and Jak2
(Fig. 3B). We also examined the phosphorylation level of STAT1 until
24 h after IFN-γ stimulation, but no signiﬁcant changes were
detected (data not shown). Figs. 3A and B showed no changes of allcted with pCAG-MV-N expression plasmid. 24 h later, the cells were treated with IFN-α
n plasmid. 24 h later, the cells were treated with IFN-γ at 1000 U/ml for 30 min, or not.
olyclonal antibody against STAT1 or STAT2. MV-N was visualized using Alexa Fluor 568
point to MV-N-expressing cells and arrows point to non-expressing cells. (C) The num-
tion was determined by counting about 50 cells each in random microscopic ﬁelds.
Fig. 5 (continued).
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Then we conﬁrmed the experimental system using NiV-P expression
cell. In the result, NiV-P blocked STAT1 phosphorylation in this experi-
ment as previously reported (Shaw et al., 2004) (Fig. 3C). These results
mean that the IFN-α/β or IFN-γ-dependent activations of STATs and
Jaks' proteins are certainly not targeted by MV-N.
In the rubulavirus, it is known that V protein prevents IFN signaling
by inducing STAT degradation (Didcock et al., 1999; Parisien et al., 2001,
2002; Ulane and Horvath, 2002; Ulane et al., 2003). Therefore, to deter-
mine ifMV-N induces STAT degradation, total cell lysateswere analyzed
byWestern blot probedwith antibodies speciﬁc for STAT1 or STAT2. No
reduction was observed in the levels of STAT1 and STAT2 proteins by
MV-N expression (Figs. 3A and B). This result veriﬁes that MV-N does
not induce STAT protein degradation.
MV-N has no effect on the formation of pSTAT dimer
In SeV infected cells, both STAT1 and phospho-STAT1 (pSTAT1) are
present in the form of aberrant high molecular weight complexes
(HMWCs), not as a pSTAT1 homodimer or STAT1 monomer. HMWC
formation is suggested to be linked to the blockade of IFN signaling to
STAT1.
To determine whether the dimerization of pSTAT takes place
normally in MV-N expression cells, native PAGE was performed,
which would allow separation of the monomeric and dimeric forms
(Shuai et al., 1994). STAT and pSTAT were visualized by Western blot
analysis (Fig. 4A). The pSTAT1 and pSTAT2 heterodimers were detected
in cells transfected with both empty vector and the MV-N expression
plasmid after IFN-α stimulation. The other higher molecular weight
complex was not detected. The pSTAT1 homodimer, known as GAF,was also detected in response to IFN-γ stimulation, and the other higher
molecular weight complex was not detected (Fig. 4B). These results
suggest that MV-N has no effect on the formation of STAT dimers.
MV-N prevents IFN-induced nuclear accumulation of STAT
To investigate the effects ofMV-N on STAT intracellular distribution,
indirect immunoﬂuorescence was used to visualize the subcellular
localization of MV-N and STATs. STAT1 or STAT2 was found in both
the nucleus and cytoplasm in unstimulated cells, a result of balanced
signal-independent basal nuclear shuttling (Marg et al., 2004; Meyer
et al., 2002; Schindler et al., 1992) (Fig. 5A). MV-N was found in both
the nucleus and the cytoplasm, as previously reported (Sato et al.,
2006), and the MV-N expression did not alter the basal distribution of
STATs (Fig. 5A). In response to IFN-α stimulation, STAT1 and STAT2 rap-
idly translocate to the nucleus and cells exhibit strong nuclear staining
(Rodriguez et al., 2002; Schindler et al., 1992), as observed in control
cells not expressingMV-N (Fig. 5A, arrow). However, in cells expressing
MV-N, STAT1 and STAT2 failed to accumulate in nucleus after IFN-α
treatment (Fig. 5A, arrowhead). Similarly, in the IFN-γ stimulated
cells, STAT1 translocates to the nucleus (Fig. 5B, arrow), and MV-N
also inhibits nuclear translocation of STAT1 in almost all cells (Fig. 5B,
arrowhead). The subcellular locations of STAT1 and STAT2 in MV-N
transfected and/or IFN stimulated cells were scored according to the
cell distribution pattern as mainly in nuclear or homogenous
(nuclear+cytosolic) (Fig. 5C). All cells without IFN stimulation showed
a homogenous distribution pattern of STAT1 and almost all cells
(95.8–98.0%) showed a homogenous distribution pattern of STAT2.
After IFN-α stimulation, STAT1 translocated to the nucleus in 86.0%
cells and STAT2 translocated to the nucleus in 78.0% cells. In MV-N
Fig. 6. The nucleocytoplasmic transport of MV-N is essential for IFN signaling inhibi-
tion. (A) HEK-293T cells were transfected with pISRE-Luc, phRL-TK(Int−) and either
empty vector or an appropriate protein (MV-N(70–73A) and MV-N(74–77A)) expres-
sion plasmid. Cells were treated with 1000 U/ml IFN-α for 24 h prior to lysis and lucif-
erase assays. (B) The same experiment was conducted using pGAS-Luc with 1000 U/ml
IFN-γ. The results are expressed as induction (n-fold) relative to the value obtained
from experiments without treatment. The data represent means±SD for triplicate
samples. Statistics were performed using the Student's t-test; *Pb0.05, **Pb0.01 com-
pared to MV-N. (C) Western blotting for MV-N mutants using with A lysates is shown.
50 I. Takayama et al. / Virology 424 (2012) 45–55expressing cells, on the contrary, STAT1 translocated to the nucleus only
in 10.9% cells and STAT2 translocated in 22.0%. After IFN-γ stimulation,
STAT1 translocated to the nucleus in 90.0% cells. On the other hand,
STAT1 translocated to the nucleus in 14.6% cells expressing MV-N
(Fig. 5C). Previous reports have been indicated that STAT1–STAT2
heterodimer and STAT1 homodimer induced by IFN-α and IFN-γ,
respectively, bind to importin α5, and are transported into nuclei
(Fagerlund et al., 2002; McBride et al., 2002; Sekimoto et al., 1997). To
analyze whether MV-N affects on the importin α5-mediated nuclear
transport other than STATs, a cellular protein, Kir/GemW269E, which
has been demonstrated to be transported into nucleus by importin α5
speciﬁcally (Mahalakshmi et al., 2007), was expressed together with
or without MV-N. As a result, MV-N overexpression did not alter the
intracellular localization of Kir/GemW269E (data not shown). These
results suggested that MV-N does not interfere with general transport
by importin α5, but inhibits IFN-α/β or IFN-γ signaling at the level of
STAT nuclear translocation speciﬁcally.The nucleocytoplasmic transport of MV-N is essential for IFN signaling
inhibition
MV-V, amajor IFN-antagonist, interactswith STAT1, and the interac-
tion is considered to inhibit IFN signaling (Palosaari et al., 2003). A
co-immunoprecipitation assay was performed to determine if MV-N
interferes with the nucleocytoplasmic transport of STAT1 by direct
binding with STAT1. We did not ﬁnd any direct binding in this assay
(data not shown).
Previous reports have indicated that morbillivirus N protein has an
intrinsic ability to migrate into the nucleus when expressed inmammali-
an cells (Huber et al., 1991; Shin et al., 1997). Moreover, morbilliviruses
are unique and are distinct from other paramyxoviruses in that intranuc-
lear inclusion bodies are formed in infected tissues of patients (Grifﬁn,
2001). These are accumulation of viral nucleocapsid particles, which are
composed of N protein and the viral RNA genome, and are characteristic
of late-stage morbillivirus infection (Huber et al., 1991; Koestner and
Long, 1970; Oyanagi et al., 1971; Raine et al., 1969, 1971).
The nuclear localization signals (NLS) of MV-N were previously
characterized at amino acid residues 70–77 (Sato et al., 2006). Nuclear
transport of two mutants, MV-N(70–73A) and MV-N(74–77A), intro-
duced by alanine substitution mutagenesis at positions 70–73 and
74–77, respectively, was markedly disrupted. To verify whether the
nucleocytoplasmic transport of MV-N prevents activated-STAT nuclear
accumulation, we performed IFN-α/β and IFN-γ luciferase reporter
gene assays with these two mutants. The assay was performed as
described in Fig. 1 with transfection of these two mutants instead of
the MV-N expression plasmid. In the IFN-α/β reporter gene assay, the
two mutants showed 79–87% luciferase activity, compared with trans-
fection with an empty vector, and lost their IFN-α/β-antagonistic activ-
ity (Fig. 6A). Similarly, the two mutants lacked almost all abilities to
inhibit IFN-γ-responsive reporter gene expression (74–85%) (Fig. 6B).
We conﬁrmed this result by indirect immunoﬂuorescence. MV-
N(70–73A) and MV-N(74–77A) were found only in the cytoplasm,
as previously reported (Sato et al., 2006). In cells treated with IFN-α
the nuclear import of STAT1 and STAT2 was not disturbed by expres-
sion of MV-N(70–73A) (Fig. 7A, arrowhead). The same results were
indicated in cells expressing MV-N(74–77A) (data not shown). In
cells treated with IFN-γ, MV-N(70–73A) also did not disturb the
nuclear import of STAT1 (Fig. 7B). MV-N(74–77A) showed a similar
result (data not shown).
MV-P is known to possess ability to retain MV-N in cytoplasm in
infected cells in vitro (Huber et al., 1991). Recent report demonstrated
that MV-P mutant (Y110F, V112S, H115A) loses STAT1 antagonistic
activity but maintains N–P interaction (Devaux et al., 2007). We
conﬁrmed that co-expression of the MV-P mutant retained MV-N in
cytoplasm, and restored the interference of IFN-α/β and -γ responses
induced by MV-N, as shown in Fig. 1, to 89% and 91%, respectively.
These data suggest that the nuclear transport of MV-N plays an
important role in IFN signaling inhibition.
The N protein of other morbilliviruses also blocks IFN signaling
The N protein is the most conserved protein among viral proteins in
morbilliviruses. In particular, the N-terminal regions of N protein
(residues 1–420) demonstrate approximately 80% amino acid sequence
similarity (Parks et al., 1992). A previous report has identiﬁed that the
NLS of MV-N, CDV-N and RPV-N are located at the same position
(Sato et al., 2006). We examined IFN-α/β and IFN-γ luciferase reporter
assays with CDV-N and RPV-N. The assays were performed as described
in Fig. 1. IFN-α/β and IFN-γ signaling were blocked to an equal level or
even stronger than that ofMV-N by the expression of CDV-N and RPV-N
(Figs. 8A, B). Furthermore, we conﬁrmed that CDV-N and RPV-N inter-
fered with nuclear transport of STAT1 and STAT2, same as MV-N
(data not shown). These results suggest that N protein of morbilli-
viruses has an intrinsic ability for the inhibition of IFN signaling.
Fig. 7.MV-Nmutants within NLS cannot inhibit the activated STAT nuclear accumulation. (A) COS-7 cells were transfectedwith pCAG-MV-N(70–73A) expression plasmid. 24 h later, the
cellswere treatedwith IFN-α at 2000 U/ml for 30 min, or not. (B) COS-7 cellswere transfectedwith pCAG-MV-N(70–73A) expressionplasmid. 24 h later, the cellswere treatedwith IFN-γ
at 1000 U/ml for 30 min or not. Cells were ﬁxed, permeabilized, and stained with monoclonal antibody against MV-N and polyclonal antibody against STAT1. MV-N(70–73A) was visu-
alized using Alexa Fluor 568 (red) and STAT using Alexa Fluor 488 (green) secondary antibodies. For clarity, arrowheads point to MV-N(70–73A)-expressing cells.
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Previous research relating toMVhas revealed that the three proteins
(V, P, and C) mediate evasion of the host immune response (Devaux
et al., 2007; Fontana et al., 2008). It is agreed that V protein inhibits
IFN-α/β signaling, but there are conﬂicting reports about the suppres-
sion of IFN-γ signaling by this protein (Palosaari et al., 2003; Takeuchi
et al., 2003). In addition, Shaffer et al. demonstrated the inhibition of
an IFN-α/β-responsive reporter gene by C protein (Shaffer et al.,
2003); however, other studies reported that C protein has a minor
role in the inhibition of IFN signaling (Nakatsu et al., 2006; Ohno et al.,
2004; Takeuchi et al., 2005). In the present study, we indicated that
the C protein of HL strain could inhibit IFN signaling. Interestingly, byan IFN-promoter activation assay, we found that N protein also has
inhibitory activity on signal transduction in response to IFN, and to
the same extent as that of C protein. Moreover, it inhibits not only
IFN-α/β signaling but also IFN-γ signaling.
N protein is well conserved among the Morbillivirus, and MV has
similar features and pathogenicity to CDV and RPV. Accordingly, we
further conﬁrmed IFN inhibition by CDV-N and RPV-N. Based on our
experimental observations with CDV-N and RPV-N, it is possible to
conclude that their inhibition of the IFN signaling pathway is character-
istic of morbilliviruses (Fig. 8).
Upon infection, viral RNA rapidly induces the production of IFN-α/β
and a response to IFN in infected cells. The MV V and C proteins are not
associated with viral particles and expressed lower levels in the virus
Fig. 8. The N proteins of other morbilliviruses also block IFN signaling. (A) HEK-293T cells
were transfectedwith pISRE-Luc, phRL-TK(Int−), and either empty vector or an appropri-
ate protein (MV-N, CDV-N and RPV-N) expression plasmid. Cells were treated with
1000 U/ml IFN-α for 24 h prior to lysis and luciferase assays. (B) The same experiment
was conducted using pGAS-Lucwith 1000 U/ml IFN-γ. The results are expressed as induc-
tion (n-fold) relative to the value obtained from experiments without treatment. The data
representmeans±SD for triplicate samples. Statistics were performedusing the Student's
t-test; **Pb0.01, ***Pb0.001 compared to pCAG. (C) Western blotting for viral proteins
using with Fig. 8A lysates is shown.
52 I. Takayama et al. / Virology 424 (2012) 45–55infected cells. Meanwhile, N protein is the most abundant of the viral
proteins and synthesized soon after infection. It is predicted that
MV-N could disturb IFN response at an early-phase of infection.
We examined the MV-N inhibition mechanism step by step. MV-N
does not prevent the activation of STATs and Jaks and does not induce
the degradation of STATs (Figs. 3 and 4). In contrast, it blocks the nucle-
ar import of activated STATs (Fig. 5). MV-N is known to possess NLS
(Sato et al., 2006) and translocates to nucleus that has been often
observed as intranuclear inclusion bodies in infected tissues of patients
(Grifﬁn, 2001). Mutations within NLS in N protein in the present study
abrogated inhibition of IFN-α/β and IFN-γ signaling (Fig. 6) and the
effect of MV-Nmutants on IFN signaling was also conﬁrmed using indi-
rect immunoﬂuorescence (Fig. 7). In addition, MV-P mutant devoid of
STAT antagonist activity (Devaux et al., 2007) interferedwith the inhib-
itory activity ofMV-N on IFN-α/β and IFN-γ signaling (data not shown).
Therefore, it is suggested that the nuclear translocation of MV-N
disturbs the nuclear import of activated STATs. The mechanism of the
inhibitory effect of MV-N on the nuclear import is unknown. Our inves-
tigation (data not shown) and previous report of RPV (Nanda and
Baron, 2006) have demonstrated that N protein showed no interaction
with STAT1. MV-N inhibits STAT1 nuclear import without direct inter-
action with STAT1. Thus, some host factor should be implicated in theinhibitory effect of MV-N on STAT-translocation into nuclei. The NLS
of STAT1 was identiﬁed, and the sequence is nonclassical NLS. An
importin α5 mediates nuclear transport of STATs (Fagerlund et al.,
2002;McBride et al., 2002; Sekimoto et al., 1997).Weanalyzedwhether
MV-N affects on the other importinα5-mediatednuclear transport. As a
result, MV-N overexpression did not alter the intracellular localization
of Kir/GemW269E, which is transported by importin α5 (data not
shown). Furthermore, we conﬁrmed whether MV-N interacts with
importin family by co-immunoprecipitation assay, but speciﬁc interac-
tion has not been observed (data not shown). These results suggest
that MV-N does not interfere with general transport by importin α5,
but targets nuclear translocation of pSTAT speciﬁcally. We are investi-
gating how MV-N inhibits pSTAT nuclear transport. Further experi-
ments will determine the mechanisms of the inhibition.
Previous studies indicate that MV-N binds to various host proteins
and is concerned in MV pathogenicity. It has been demonstrated that
MV-N binds to the receptor for the Fc protein of IgG, Fc-γ receptor
type II (FcγRII, CD32). This interaction inhibits human B cell antibody
production in vitro (Ravanel et al., 1997) and induces apoptosis in cell
lines (Laine et al., 2005). In addition, this interaction reduces the pro-
duction of IL-12 by dendritic cells and induces a loss of antigen-
speciﬁc T-cell proliferation ex vivo (Marie et al., 2001). MV-N is also
reported to interactwith interferon regulatory factor (IRF)-3. This inter-
action was described as leading to the phosphorylation-dependent
activation of IRF-3, and the ensuing activation of the pro-immune cyto-
kine RANTES gene (tenOever et al., 2002). Thus, it has been suggested
that MV-N plays various roles in the virus-induced immune response.
Furthermore, the C-terminal part ofMV-N binds to the 70-kDa heat-
shock protein (HSP70), which is a cytosolic protein inducible by heat
shock (Zhang et al., 2002). In vitro studies have shown that elevated
cellular levels of HSP70 are associated with increased gene expression
of MV and CDV via binding to N protein (Carsillo et al., 2006; Oglesbee
et al., 1990, 1993; Vasconcelos et al., 1998a,b). A recent study showed
that MV-N binds to the p40 subunit of eukaryotic initiation factor 3
(eIF3-p40). MV-N contributes to shut off host translation in
MV-infected cells through protein–protein interaction with eIF3 (Sato
et al., 2007). These studies indicate that MV-N has multiple functions
in various host systems.
In conclusion, our present data indicates that the N protein has a
crucial role in interfering with the host immune system. In the con-
text of viral infection, evasion of the IFN response is complicated,
and may involve interplay between multiple viral and host proteins.
The results presented here give insight into understanding how the
viral proteins of MV function as inhibitors of host IFN signaling.
Materials and methods
Cells
HEK-293T, HEK-293 (human embryonic kidney) and COS-7 (African
green monkey kidney) cells were maintained in Dulbecco's Modiﬁed
Eagle's medium (DMEM; Sigma-Aldrich, St. Louis, MO, USA) supple-
mented with 10% fetal bovine serum (Sigma), 100 U/ml penicillin G
and 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA, USA).
Plasmids
Construction of the mammalian expression plasmids encoding the
MV-HL N gene (pCAG-MV-N), P (Hagiwara et al., 2008) and V (Sato
et al., 2008)was described previously. To construct expression plasmids
encoding the MV C and M proteins, cDNAs were ampliﬁed by PCR
(Phusion; Finnzymes, Espoo, Finland) from pMV-HL (7+) encoding
the full-length genome cDNA of MV-HL (Terao-Muto et al., 2008),
with speciﬁc primers matching the ORF extremities. The cDNA frag-
ments were blunted with T4 DNA polymerase (Takara, Shiga, Japan)
and ligated into the pCAGGS mammalian expression vector (Niwa et
53I. Takayama et al. / Virology 424 (2012) 45–55al., 1991). Construction of the two mutant MV-N plasmids (pCAG-MV-
N(70-73A) and pCAG-MV-N(74-77A)) was described previously (Sato
et al., 2006). To generate the N protein of the CDV (CDV-N) expression
plasmid, cDNA was ampliﬁed by PCR from pCDV encoding the full-
length genome cDNA of CDV-Yanaka (Fujita et al., 2007) with speciﬁc
primers matching the ORF extremities, and the blunted cDNA fragment
was subcloned in the pCAGGS. To generate the N protein of RPV
(RPV-N) expression plasmid, the cDNA coding for the protein was
obtained by PCR ampliﬁcation of the full-length genome cDNA of
RPV-L (Yoneda et al., 2004) with speciﬁc primers matching the ORF
extremities, and the blunted cDNA fragment was ligated into the
pCAGGS. To generate the P protein of the NiV (NiV-P) expression plas-
mid, the cDNA coding for the protein was ligated into the pCAGGS
(Yoneda et al., 2010).
The IFN-α-inducible reporter plasmid pISRE-Luc, containing ISRE,
was obtained from Clontech (Mountain View, CA, USA). To construct
the IFN-γ-inducible reporter plasmid pGAS-Luc, three copies of the
GAS from human IRF-1 gene, 5′-AGCCTGATTTCCCCGAAATGA-3′, were
inserted in the MluI and BglII sites upstream of luciferase gene of the
pGL3-Promoter reporter plasmid (Promega, Madison, WI, USA). The
plasmid phRL-TK(Int−) (Promega) encodes the Renilla luciferase gene
constitutively expressed from a thymidine kinase promoter, and was
used as an internal control.
Antibodies
Mouse monoclonal antibody 8G (Masuda et al., 2006) recognizing
MV-N was used for the immunoﬂuorescence assay. Rabbit polyclonal
antibody against MV-N (Hagiwara et al., 2008) was used to detect
MV-N, CDV-N and RPV-N forWestern blot analysis. Rabbit polyclonal an-
tibodywas used for detectingMV-V (unpublished data). Rabbit polyclon-
al antibody against STAT1 p84/p91 (E-23), STAT2 (C-20) and rabbit
anti-phospho-STAT2 (Tyr690) were purchased from Santa Cruz (Santa
Cruz, CA, USA). Rabbit anti-phospho-STAT1 (Tyr701) was obtained from
Cell Signaling Technology (Danvers, MA, USA). Rabbit anti-phospho-
Jak1 (Tyr1022/1023) was obtained from Invitrogen. Rabbit anti-
phospho-Jak2 (Tyr1007/1008) andmousemonoclonal antibodies against
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were obtained
from Millipore (Billerica, MA, USA). The horseradish peroxidase (HRP)-
conjugated rabbit anti-mouse IgG or goat anti-rabbit IgG (Dako, Glostrup,
Denmark) was used as secondary antibodies for Western blot analysis.
Alexa Fluor 568-conjugated goat anti-mouse IgG (H+L) antibody and
Alexa Fluor 488-conjugated goat anti-rabbit IgG (H+L) antibody were
obtained from Invitrogen for the immunoﬂuorescence assay.
Luciferase reporter gene assay
HEK-293T cells (1×105 per well) were plated in 24-well plates. One
day later, they were transfected with pISRE-Luc (0.2 μg/well) or pGAS-
Luc (0.004 μg/well), phRL-TK(Int−) reference plasmid (0.001 μg/well)
and empty pCAGGS vector, or pCAGGS encoding the appropriate
protein (0.6 μg/well or the indicated amounts in the legend to Fig. 2.).
Transfection was performed with Lipofectamine 2000 Reagent
(Invitrogen) according to the manufacturer's protocol. The medium
was changed 24 h after transfection, and universal type I IFN (PBL Inter-
feronSource, Piscataway, NJ, USA) or recombinant human IFN-γ
(Sigma) was added to the medium at 1000 U/ml. After a further 24 h
of incubation, luciferase activity was measured using the Dual-Glo
Luciferase Assay System(Promega) following themanufacturer's proto-
col. Each transfection experiment was conducted in triplicate. Reporter
activity was calculated as the ratio of ﬁreﬂy luciferase activity to the
reference Renilla luciferase activity. The results are expressed as fold in-
duction, which is the value relative to the value of control experiments
without IFN treatment. A two-tailed Student's t-test was used for two-
group comparisons. To conﬁrm the gene expressions, Western blot
was performed using the cell lysates.Western blot analysis
HEK-293 or HEK-293T cells (7×105 per well) were plated in 6-well
plates. One day later, theywere transfectedwith empty pCAGGS vector,
pCAG-MV-N plasmid or pCAG-NiV-P plasmid (1 μg/well) using FuGENE
6 (Roche Diagnostics, Mannheim, Germany). Cells were treated with
1000 U/ml universal type I IFN or IFN-γ 24 h post transfection, for 10,
20, or 30 min. The cells were lysed with cell lysis buffer (20 mM
HEPES-NaOH (pH 7.5), 1% Nonidet P-40, 120 mM NaCl, 1 mM dithio-
threitol, 10% glycerol, 5 mM EDTA, 1 mM phenylmethylsulfonyl ﬂuo-
ride, 1 mM Na3VO4 and 1 mM NaF) and the lysates were centrifuged
at 10,000 g for 10 min at 4 °C. The supernatants were recovered, and
protein concentration was determined by BCA protein assay (Pierce,
Rockford, IL, USA). The proteins were separated by 5%, 7% or 10% SDS-
PAGE, and transferred to a PVDFmembrane (Immobilon-P; Millopore).
The membrane was blocked in 4% BlockAce (Dainihon Pharmaceutics,
Osaka, Japan) in phosphate-buffered saline (PBS) or 5% bovine serum
albumin (BSA) (Sigma) in Tris-buffered saline containing 0.1% Tween
20 (TBST) for 1 h at room temperature. After overnight incubation at
4 °C with a primary antibody, the membranes were washed in TBST
for 15 min and incubated at room temperature with a secondary anti-
body for 1 h. The membranes were washed in TBST for 15 min and
detected using ECL or ECL Plus Western blotting detection reagents
(GE Healthcare, Buckinghamshire, UK). The chemiluminescent signals
were detected and visualized using a LAS-1000 mini (Fujiﬁlm, Tokyo,
Japan).
Nondenaturing polyacrylamide gel analysis
HEK-293 orHEK-293T cells grown in 60-mmdishes to approximate-
ly 80% conﬂuence were transfected with empty pCAGGS vector or with
pCAG-MV-N plasmid using FuGENE 6. At 24 h post transfection, cells
were treated with 1000 U/ml universal type I IFN or IFN-γ for 6 h. The
cells were lysed as mentioned above. The extracts were separated on
8% polyacrylamide gel in Tris–Glycine Native running buffer, and then
transferred to a PVDF membrane with transfer buffer for native PAGE
(48 mM Tris, 39 mM glycine, 20% methanol, 0.1% SDS). The membrane
was blocked and immunoblotted as described above.
Immunoﬂuorescence
COS-7 cells (4×104 per well) were seeded on coverslips on 24-well
plates and transfected with empty vector or pCAGGS encoding the
appropriate protein (0.2 μg/well) using FuGENE6. At 24 h post transfec-
tion, cells were treated with 2000 U/ml universal type I IFN or
1000 U/ml IFN-γ for 30 min at 37 °C. Transfected cells were washed
three times with ice-cold PBS, ﬁxed in 4% paraformaldehyde for
30 min, permeabilized for 4 min with PBS containing 0.1% Triton
X-100, and blocked for 30 min in PBS containing 2% BSA and 0.1% Triton
X-100. The cells were then incubated overnight with a primary anti-
body against STAT1 or STAT2 and a monoclonal antibody against MV-
N in PBS containing 2% BSA and 0.1% Triton X-100 at 4 °C, before
beingwashed in PBS. Theywere subsequently incubatedwith an appro-
priate secondary antibody for 1 h at room temperature. After three
washes in TBST, the ﬂuorescent signals were visualized by confocal
laser microscopy (Olympus, Tokyo, Japan). Hoechst 33342 (Lonza,
Basel, Switzerland) was used as a nuclear stain. The subcellular localiza-
tion of STAT1 and STAT2was divided into two groups, displayingmain-
ly nuclear or homogenous (nuclear+cytosolic). The number of cells
was determined by counting about 50 cells each in randommicroscopic
ﬁelds. Each experiment was conducted in triplicate.
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